Dechra Pharmaceuticals Plc Reports Another Set Of Solid Numbers For FY19

  • Sep 02, 2019 BST
  • Team Kalkine

Dechra Pharmaceuticals plc (LSE: DPH), has reported another solid performance for the Financial Year ended 30 June 2019. There was an all-round performance of the group and the revenue for the year surged by 17.5% to £481.8 million from £407.1 million in the FY2018. The underlying operating profit growth was of 27.3% to £127.4 million from £99.2 million of the last year. Operating profit of the group improved by 13.5% to £39.0 million from £34.1 million in FY2018. On the operational front, all the acquisitions’ performance was better than expected during the year.

On 2nd September 2019, at the time of writing, GMT 08:03 AM, DPH shares were trading at GBX 3,080.00, up by 80.00 points or 2.67% against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK